JAGUAR HEALTH INC (JAGX) Stock Analyst Ratings
USA - NASDAQ:JAGX - US47010C8881 - Common Stock
1.99 USD
-0.02 (-1%)
ChartMill assigns a Buy % Consensus number of 86% to JAGX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 16.32. This target is 720.1% above the current price.
JAGX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about JAGX.
In the previous month the buy percentage consensus was at a similar level.
JAGX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-05-19 | First Berlin | Initiate | Buy |
| 2021-07-07 | Cantor Fitzgerald | Initiate | Overweight |